世界の感染症治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Infectious Disease Therapeutics Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z3146 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥565,500 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥848,250 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,131,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、感染症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（治療薬、ワクチン）、用途別市場規模（HIV/AIDS、インフルエンザ、肝炎、マラリア、結核、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・感染症治療の市場動向 ・企業の競争状況、市場シェア ・感染症治療の種類別市場規模（治療薬、ワクチン） ・感染症治療の用途別市場規模（HIV/AIDS、インフルエンザ、肝炎、マラリア、結核、その他） ・感染症治療の北米市場規模2016-2027（アメリカ、カナダ） ・感染症治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・感染症治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・感染症治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・感染症治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Novartis AG、Gilead、GlaxoSmithKline plc、Janssen Pharmaceutical Inc.、F. Hoffmann-La Roche Ltd.、BioCryst Pharmaceuticals Inc.、Merck & Co. Inc.、Boehringer Ingelheim GmbH） ・結論

Infectious disease therapeutics are targeting on main infectious diseases by using drugs and vaccines to prevent, control and cure them.
Major driving factors of the global infectious disease therapeutics market are favorable reimbursement policies for infectious diseases, increasing incidence of infectious diseases, escalating consumption of anti-microbial direct acting drugs, growing geriatric population, rising awareness among population, upsurge in government investment into healthcare to eradicate infectious diseases.

Market Analysis and Insights: Global Infectious Disease Therapeutics Market
The global Infectious Disease Therapeutics market size is projected to reach US$ 59310 million by 2026, from US$ 45730 million in 2019, at a CAGR of 3.7% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Infectious Disease Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Infectious Disease Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Infectious Disease Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Infectious Disease Therapeutics market.

Global Infectious Disease Therapeutics Scope and Market Size
Infectious Disease Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Infectious Disease Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Drugs
Vaccines

Segment by Application
HIV/AIDS
Influenza
Hepatitis
Malaria
Tuberculosis
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Novartis AG
Gilead
GlaxoSmithKline plc
Janssen Pharmaceutical Inc.
F. Hoffmann-La Roche Ltd.
BioCryst Pharmaceuticals Inc.
Merck & Co. Inc.
Boehringer Ingelheim GmbH

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Infectious Disease Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Drugs
1.2.3 Vaccines
1.3 Market by Application
1.3.1 Global Infectious Disease Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 HIV/AIDS
1.3.3 Influenza
1.3.4 Hepatitis
1.3.5 Malaria
1.3.6 Tuberculosis
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Infectious Disease Therapeutics Market Perspective (2016-2027)
2.2 Infectious Disease Therapeutics Growth Trends by Regions
2.2.1 Infectious Disease Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Infectious Disease Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Infectious Disease Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Infectious Disease Therapeutics Industry Dynamic
2.3.1 Infectious Disease Therapeutics Market Trends
2.3.2 Infectious Disease Therapeutics Market Drivers
2.3.3 Infectious Disease Therapeutics Market Challenges
2.3.4 Infectious Disease Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Infectious Disease Therapeutics Players by Revenue
3.1.1 Global Top Infectious Disease Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Infectious Disease Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Infectious Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Infectious Disease Therapeutics Revenue
3.4 Global Infectious Disease Therapeutics Market Concentration Ratio
3.4.1 Global Infectious Disease Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Infectious Disease Therapeutics Revenue in 2020
3.5 Infectious Disease Therapeutics Key Players Head office and Area Served
3.6 Key Players Infectious Disease Therapeutics Product Solution and Service
3.7 Date of Enter into Infectious Disease Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Infectious Disease Therapeutics Breakdown Data by Type
4.1 Global Infectious Disease Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Infectious Disease Therapeutics Forecasted Market Size by Type (2022-2027)

5 Infectious Disease Therapeutics Breakdown Data by Application
5.1 Global Infectious Disease Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Infectious Disease Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Infectious Disease Therapeutics Market Size (2016-2027)
6.2 North America Infectious Disease Therapeutics Market Size by Type
6.2.1 North America Infectious Disease Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Infectious Disease Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Infectious Disease Therapeutics Market Size by Type (2016-2027)
6.3 North America Infectious Disease Therapeutics Market Size by Application
6.3.1 North America Infectious Disease Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Infectious Disease Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Infectious Disease Therapeutics Market Size by Application (2016-2027)
6.4 North America Infectious Disease Therapeutics Market Size by Country
6.4.1 North America Infectious Disease Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Infectious Disease Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Infectious Disease Therapeutics Market Size (2016-2027)
7.2 Europe Infectious Disease Therapeutics Market Size by Type
7.2.1 Europe Infectious Disease Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Infectious Disease Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Infectious Disease Therapeutics Market Size by Type (2016-2027)
7.3 Europe Infectious Disease Therapeutics Market Size by Application
7.3.1 Europe Infectious Disease Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Infectious Disease Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Infectious Disease Therapeutics Market Size by Application (2016-2027)
7.4 Europe Infectious Disease Therapeutics Market Size by Country
7.4.1 Europe Infectious Disease Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Infectious Disease Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Infectious Disease Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Infectious Disease Therapeutics Market Size by Type
8.2.1 Asia-Pacific Infectious Disease Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Infectious Disease Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Infectious Disease Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Infectious Disease Therapeutics Market Size by Application
8.3.1 Asia-Pacific Infectious Disease Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Infectious Disease Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Infectious Disease Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Infectious Disease Therapeutics Market Size by Region
8.4.1 Asia-Pacific Infectious Disease Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Infectious Disease Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Infectious Disease Therapeutics Market Size (2016-2027)
9.2 Latin America Infectious Disease Therapeutics Market Size by Type
9.2.1 Latin America Infectious Disease Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Infectious Disease Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Infectious Disease Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Infectious Disease Therapeutics Market Size by Application
9.3.1 Latin America Infectious Disease Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Infectious Disease Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Infectious Disease Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Infectious Disease Therapeutics Market Size by Country
9.4.1 Latin America Infectious Disease Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Infectious Disease Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Infectious Disease Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Infectious Disease Therapeutics Market Size by Type
10.2.1 Middle East & Africa Infectious Disease Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Infectious Disease Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Infectious Disease Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Infectious Disease Therapeutics Market Size by Application
10.3.1 Middle East & Africa Infectious Disease Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Infectious Disease Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Infectious Disease Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Infectious Disease Therapeutics Market Size by Country
10.4.1 Middle East & Africa Infectious Disease Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Infectious Disease Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Novartis AG
11.1.1 Novartis AG Company Details
11.1.2 Novartis AG Business Overview
11.1.3 Novartis AG Infectious Disease Therapeutics Introduction
11.1.4 Novartis AG Revenue in Infectious Disease Therapeutics Business (2016-2021)
11.1.5 Novartis AG Recent Development
11.2 Gilead
11.2.1 Gilead Company Details
11.2.2 Gilead Business Overview
11.2.3 Gilead Infectious Disease Therapeutics Introduction
11.2.4 Gilead Revenue in Infectious Disease Therapeutics Business (2016-2021)
11.2.5 Gilead Recent Development
11.3 GlaxoSmithKline plc
11.3.1 GlaxoSmithKline plc Company Details
11.3.2 GlaxoSmithKline plc Business Overview
11.3.3 GlaxoSmithKline plc Infectious Disease Therapeutics Introduction
11.3.4 GlaxoSmithKline plc Revenue in Infectious Disease Therapeutics Business (2016-2021)
11.3.5 GlaxoSmithKline plc Recent Development
11.4 Janssen Pharmaceutical Inc.
11.4.1 Janssen Pharmaceutical Inc. Company Details
11.4.2 Janssen Pharmaceutical Inc. Business Overview
11.4.3 Janssen Pharmaceutical Inc. Infectious Disease Therapeutics Introduction
11.4.4 Janssen Pharmaceutical Inc. Revenue in Infectious Disease Therapeutics Business (2016-2021)
11.4.5 Janssen Pharmaceutical Inc. Recent Development
11.5 F. Hoffmann-La Roche Ltd.
11.5.1 F. Hoffmann-La Roche Ltd. Company Details
11.5.2 F. Hoffmann-La Roche Ltd. Business Overview
11.5.3 F. Hoffmann-La Roche Ltd. Infectious Disease Therapeutics Introduction
11.5.4 F. Hoffmann-La Roche Ltd. Revenue in Infectious Disease Therapeutics Business (2016-2021)
11.5.5 F. Hoffmann-La Roche Ltd. Recent Development
11.6 BioCryst Pharmaceuticals Inc.
11.6.1 BioCryst Pharmaceuticals Inc. Company Details
11.6.2 BioCryst Pharmaceuticals Inc. Business Overview
11.6.3 BioCryst Pharmaceuticals Inc. Infectious Disease Therapeutics Introduction
11.6.4 BioCryst Pharmaceuticals Inc. Revenue in Infectious Disease Therapeutics Business (2016-2021)
11.6.5 BioCryst Pharmaceuticals Inc. Recent Development
11.7 Merck & Co. Inc.
11.7.1 Merck & Co. Inc. Company Details
11.7.2 Merck & Co. Inc. Business Overview
11.7.3 Merck & Co. Inc. Infectious Disease Therapeutics Introduction
11.7.4 Merck & Co. Inc. Revenue in Infectious Disease Therapeutics Business (2016-2021)
11.7.5 Merck & Co. Inc. Recent Development
11.8 Boehringer Ingelheim GmbH
11.8.1 Boehringer Ingelheim GmbH Company Details
11.8.2 Boehringer Ingelheim GmbH Business Overview
11.8.3 Boehringer Ingelheim GmbH Infectious Disease Therapeutics Introduction
11.8.4 Boehringer Ingelheim GmbH Revenue in Infectious Disease Therapeutics Business (2016-2021)
11.8.5 Boehringer Ingelheim GmbH Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Infectious Disease Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Drugs
Table 3. Key Players of Vaccines
Table 4. Global Infectious Disease Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Infectious Disease Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Infectious Disease Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Infectious Disease Therapeutics Market Share by Regions (2016-2021)
Table 8. Global Infectious Disease Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Infectious Disease Therapeutics Market Share by Regions (2022-2027)
Table 10. Infectious Disease Therapeutics Market Trends
Table 11. Infectious Disease Therapeutics Market Drivers
Table 12. Infectious Disease Therapeutics Market Challenges
Table 13. Infectious Disease Therapeutics Market Restraints
Table 14. Global Infectious Disease Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Infectious Disease Therapeutics Market Share by Players (2016-2021)
Table 16. Global Top Infectious Disease Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Infectious Disease Therapeutics as of 2020)
Table 17. Ranking of Global Top Infectious Disease Therapeutics Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Infectious Disease Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Infectious Disease Therapeutics Product Solution and Service
Table 21. Date of Enter into Infectious Disease Therapeutics Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Infectious Disease Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Infectious Disease Therapeutics Revenue Market Share by Type (2016-2021)
Table 25. Global Infectious Disease Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Infectious Disease Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Infectious Disease Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Infectious Disease Therapeutics Revenue Market Share by Application (2016-2021)
Table 29. Global Infectious Disease Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Infectious Disease Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Infectious Disease Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Infectious Disease Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Infectious Disease Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Infectious Disease Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Infectious Disease Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Infectious Disease Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Infectious Disease Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Infectious Disease Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Infectious Disease Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Infectious Disease Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Infectious Disease Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Infectious Disease Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Infectious Disease Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Infectious Disease Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Infectious Disease Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Infectious Disease Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Infectious Disease Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Infectious Disease Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Infectious Disease Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Infectious Disease Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Infectious Disease Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Infectious Disease Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Infectious Disease Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Infectious Disease Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Infectious Disease Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Infectious Disease Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Infectious Disease Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Infectious Disease Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Infectious Disease Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Infectious Disease Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 61. Novartis AG Company Details
Table 62. Novartis AG Business Overview
Table 63. Novartis AG Infectious Disease Therapeutics Product
Table 64. Novartis AG Revenue in Infectious Disease Therapeutics Business (2016-2021) & (US$ Million)
Table 65. Novartis AG Recent Development
Table 66. Gilead Company Details
Table 67. Gilead Business Overview
Table 68. Gilead Infectious Disease Therapeutics Product
Table 69. Gilead Revenue in Infectious Disease Therapeutics Business (2016-2021) & (US$ Million)
Table 70. Gilead Recent Development
Table 71. GlaxoSmithKline plc Company Details
Table 72. GlaxoSmithKline plc Business Overview
Table 73. GlaxoSmithKline plc Infectious Disease Therapeutics Product
Table 74. GlaxoSmithKline plc Revenue in Infectious Disease Therapeutics Business (2016-2021) & (US$ Million)
Table 75. GlaxoSmithKline plc Recent Development
Table 76. Janssen Pharmaceutical Inc. Company Details
Table 77. Janssen Pharmaceutical Inc. Business Overview
Table 78. Janssen Pharmaceutical Inc. Infectious Disease Therapeutics Product
Table 79. Janssen Pharmaceutical Inc. Revenue in Infectious Disease Therapeutics Business (2016-2021) & (US$ Million)
Table 80. Janssen Pharmaceutical Inc. Recent Development
Table 81. F. Hoffmann-La Roche Ltd. Company Details
Table 82. F. Hoffmann-La Roche Ltd. Business Overview
Table 83. F. Hoffmann-La Roche Ltd. Infectious Disease Therapeutics Product
Table 84. F. Hoffmann-La Roche Ltd. Revenue in Infectious Disease Therapeutics Business (2016-2021) & (US$ Million)
Table 85. F. Hoffmann-La Roche Ltd. Recent Development
Table 86. BioCryst Pharmaceuticals Inc. Company Details
Table 87. BioCryst Pharmaceuticals Inc. Business Overview
Table 88. BioCryst Pharmaceuticals Inc. Infectious Disease Therapeutics Product
Table 89. BioCryst Pharmaceuticals Inc. Revenue in Infectious Disease Therapeutics Business (2016-2021) & (US$ Million)
Table 90. BioCryst Pharmaceuticals Inc. Recent Development
Table 91. Merck & Co. Inc. Company Details
Table 92. Merck & Co. Inc. Business Overview
Table 93. Merck & Co. Inc. Infectious Disease Therapeutics Product
Table 94. Merck & Co. Inc. Revenue in Infectious Disease Therapeutics Business (2016-2021) & (US$ Million)
Table 95. Merck & Co. Inc. Recent Development
Table 96. Boehringer Ingelheim GmbH Company Details
Table 97. Boehringer Ingelheim GmbH Business Overview
Table 98. Boehringer Ingelheim GmbH Revenue in Infectious Disease Therapeutics Business (2016-2021) & (US$ Million)
Table 99. Boehringer Ingelheim GmbH Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Infectious Disease Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Drugs Features
Figure 3. Vaccines Features
Figure 4. Global Infectious Disease Therapeutics Market Share by Application: 2020 VS 2027
Figure 5. HIV/AIDS Case Studies
Figure 6. Influenza Case Studies
Figure 7. Hepatitis Case Studies
Figure 8. Malaria Case Studies
Figure 9. Tuberculosis Case Studies
Figure 10. Others Case Studies
Figure 11. Infectious Disease Therapeutics Report Years Considered
Figure 12. Global Infectious Disease Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Infectious Disease Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Infectious Disease Therapeutics Market Share by Regions: 2020 VS 2027
Figure 15. Global Infectious Disease Therapeutics Market Share by Regions (2022-2027)
Figure 16. Global Infectious Disease Therapeutics Market Share by Players in 2020
Figure 17. Global Top Infectious Disease Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Infectious Disease Therapeutics as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Infectious Disease Therapeutics Revenue in 2020
Figure 19. Global Infectious Disease Therapeutics Revenue Market Share by Type (2016-2021)
Figure 20. Global Infectious Disease Therapeutics Revenue Market Share by Type (2022-2027)
Figure 21. North America Infectious Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Infectious Disease Therapeutics Market Share by Type (2016-2027)
Figure 23. North America Infectious Disease Therapeutics Market Share by Application (2016-2027)
Figure 24. North America Infectious Disease Therapeutics Market Share by Country (2016-2027)
Figure 25. United States Infectious Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Infectious Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Infectious Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Infectious Disease Therapeutics Market Share by Type (2016-2027)
Figure 29. Europe Infectious Disease Therapeutics Market Share by Application (2016-2027)
Figure 30. Europe Infectious Disease Therapeutics Market Share by Country (2016-2027)
Figure 31. Germany Infectious Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Infectious Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Infectious Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Infectious Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Infectious Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Infectious Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Infectious Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Infectious Disease Therapeutics Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Infectious Disease Therapeutics Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Infectious Disease Therapeutics Market Share by Region (2016-2027)
Figure 41. China Infectious Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Infectious Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Infectious Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Infectious Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Infectious Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Infectious Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Infectious Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Infectious Disease Therapeutics Market Share by Type (2016-2027)
Figure 49. Latin America Infectious Disease Therapeutics Market Share by Application (2016-2027)
Figure 50. Latin America Infectious Disease Therapeutics Market Share by Country (2016-2027)
Figure 51. Mexico Infectious Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Infectious Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Infectious Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Infectious Disease Therapeutics Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Infectious Disease Therapeutics Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Infectious Disease Therapeutics Market Share by Country (2016-2027)
Figure 57. Turkey Infectious Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Infectious Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Infectious Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Novartis AG Revenue Growth Rate in Infectious Disease Therapeutics Business (2016-2021)
Figure 61. Gilead Revenue Growth Rate in Infectious Disease Therapeutics Business (2016-2021)
Figure 62. GlaxoSmithKline plc Revenue Growth Rate in Infectious Disease Therapeutics Business (2016-2021)
Figure 63. Janssen Pharmaceutical Inc. Revenue Growth Rate in Infectious Disease Therapeutics Business (2016-2021)
Figure 64. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Infectious Disease Therapeutics Business (2016-2021)
Figure 65. BioCryst Pharmaceuticals Inc. Revenue Growth Rate in Infectious Disease Therapeutics Business (2016-2021)
Figure 66. Merck & Co. Inc. Revenue Growth Rate in Infectious Disease Therapeutics Business (2016-2021)
Figure 67. Boehringer Ingelheim GmbH Revenue Growth Rate in Infectious Disease Therapeutics Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

---